Tivic Health Systems Return on Tangible Equity 2020-2025 | TIVC
Current and historical return on tangible equity values for Tivic Health Systems (TIVC) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Tivic Health Systems Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.01B | $0.00B | -400.00% |
| 2025-06-30 | $-0.01B | $0.00B | -300.00% |
| 2025-03-31 | $-0.01B | $0.00B | -181.82% |
| 2024-12-31 | $0.00B | $0.00B | -133.33% |
| 2024-09-30 | $-0.01B | $0.00B | -153.85% |
| 2024-06-30 | $-0.01B | $0.00B | -150.00% |
| 2024-03-31 | $-0.01B | $0.00B | -186.67% |
| 2023-12-31 | $-0.01B | $0.00B | -177.78% |
| 2023-09-30 | $-0.01B | $0.01B | -177.78% |
| 2023-06-30 | $-0.01B | $0.00B | -200.00% |
| 2023-03-31 | $-0.01B | $0.01B | -173.91% |
| 2022-12-31 | $-0.01B | $0.00B | -137.93% |
| 2022-09-30 | $-0.01B | $0.01B | -126.32% |
| 2022-06-30 | $-0.01B | $0.01B | -137.50% |
| 2022-03-31 | $-0.01B | $0.01B | -150.00% |
| 2021-12-31 | $-0.01B | $0.01B | -246.15% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.002B | $0.001B |
| Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.977B | 41.61 |
| Tempus AI (TEM) | United States | $12.325B | 0.00 |
| Doximity (DOCS) | United States | $7.582B | 31.22 |
| Hims & Hers Health (HIMS) | United States | $7.130B | 58.00 |
| IRHYTHM HLDGS (IRTC) | United States | $5.259B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $2.979B | 0.00 |
| Privia Health (PRVA) | United States | $2.811B | 175.77 |
| Inspire Medical Systems (INSP) | United States | $2.704B | 44.74 |
| 10x Genomics (TXG) | United States | $2.647B | 0.00 |
| Omnicell (OMCL) | United States | $2.276B | 46.53 |
| Azenta (AZTA) | United States | $1.817B | 74.53 |
| Clover Health Investments (CLOV) | United States | $1.452B | 0.00 |
| Enovis (ENOV) | United States | $1.388B | 7.29 |
| Schrodinger (SDGR) | United States | $1.350B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.250B | 0.00 |
| Phreesia (PHR) | United States | $0.971B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.865B | 0.00 |
| Talkspace (TALK) | United States | $0.628B | 126.33 |
| Standard BioTools (LAB) | United States | $0.611B | 0.00 |
| Claritev (CTEV) | United States | $0.504B | 0.00 |
| Evolent Health (EVH) | United States | $0.435B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| Carlsmed (CARL) | United States | $0.339B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 15.14 |
| Zepp Health (ZEPP) | Netherlands | $0.299B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.293B | 0.00 |
| CapsoVision (CV) | United States | $0.276B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.258B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.196B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.174B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.169B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.122B | 6.67 |
| Outset Medical (OM) | United States | $0.099B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| HeartBeam (BEAT) | United States | $0.079B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.072B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.042B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.023B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |